CMAC
Home
Journal Archive
Subscription
About
About
Author Guidelines
Editorial Board
Peer Review
Publishing Ethics
English
Русский
CMAC 2020; 22(2)
Type
Review
Letter to the Editor
Original Article
Sections
Antimicrobial Resistance
Antimicrobials
Diseases and Pathogens
Personal Experience
Letter to editors
Zaitsev A.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):84-86
10.36488/cmac.2020.2.84-86
PDF
Cite
Efficacy of methylprednisolone pulse therapy in patients with COVID-19
Objective. To assess efficacy and safety of methylprednisolone pulse therapy in patients with COVID-19. Materials and Methods. A …
Zaitsev A.A.
,
Golukhova E.Z.
,
Mamalyga M.L.
,
Chernov S.A.
,
Rybka M.M.
,
Kryukov E.V.
,
Klyuchnikov I.V.
,
Semyonov V.Yu.
,
Orlov I.N.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):88-91
10.36488/cmac.2020.2.88-91
PDF
Cite
The genetic characteristics of
Neisseria meningitidis
causing invasive meningococcal infections in Smolensk region
Objective. To determine antigenic and genetic characteristics of Neisseria meningitidis isolated from the patients with invasive …
Mironov K.O.
,
Yarygina E.A.
,
Chagaryan A.N.
,
Ivanchik N.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):92-95
10.36488/cmac.2020.2.92-95
PDF
Cite
The tablet formulation of posaconazole: clinical pharmacology and the use in patients with hematologic malignancies
Posaconazole is a broad-spectrum triazole antifungal agent with potent activity against various fungi, including yeast and molds, …
Veselov A.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):96-117
10.36488/cmac.2020.2.96-117
PDF
Cite
Results of an open-label, randomized, comparative clinical trial of nifuratel in the eradication of
Helicobacter pylori
infection in adult patients
Objective. To assess efficacy and safety of 14-day triple nifuratel-based therapy compared to 14-day standard triple therapy in adult …
Dekhnich N.N.
,
Tryapyshko A.A.
,
Trushin I.V.
,
KuzmenkovA.Yu.
,
Kozlov R.S.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):119-127
10.36488/cmac.2020.2.119-127
PDF
Cite
Potentiation of antimicrobial activity of colistin with antibiotics of different groups against multidrug- and extensively drug-resistant strains of
Klebsiella pneumoniae
,
Acinetobacter baumannii
and
Pseudomonas aeruginosa
Objective. To reveal antibiotics being capable of potentiating the antimicrobial activity of colistin against multidrug- and …
Tapalskiy D.V.
,
Petrovskaya T.A.
,
Kozlova A.I.
,
Edelstein M.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):128-136
10.36488/cmac.2020.2.128-136
PDF
Cite
Data handling as a basis for local antimicrobial resistance surveillance
Continuing trends of antimicrobial resistance growth require a set of countermeasures, of which antimicrobial resistance surveillance …
Vinogradova A.G.
,
Kuzmenkov A.Yu.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):137-141
10.36488/cmac.2020.2.137-141
PDF
Cite
Antimicrobial resistance of gram-negative pathogens isolated from hospitalized patients in Rostov region
Objective. To evaluate resistance rates to carbapenems and III–IV generation cephalosporins among gramnegative bacteria, including …
Kutsevalova O.Yu.
,
Kozel Yu.Yu.
,
Rozenko D.A.
,
Martynov D.V.
,
Korshunkova O.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):143-148
10.36488/cmac.2020.2.143-148
PDF
Cite
Nasopharyngeal carriage of
Streptococcus pneumoniae
in children from day-care centers in Smolensk
Objective. To investigate a nasopharyngeal carriage and serotypes of S. pneumoniae in children aged 3 to 6 years from day-care centers …
Zharkova L.P.
,
Krechikova O.I.
,
Chagaryan A.N.
,
Kozlov R.S.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):149-153
10.36488/cmac.2020.2.149-153
PDF
Cite
Imaging of the bacterial interactions in lung co-infection in cystic fibrosis patients
Objective. To identify bacterial interactions at the site of infection in cystic fibrosis patients and to assess their possible effects …
Burkaltseva M.V.
,
Lazareva A.V.
,
Pleteneva E.A.
,
Shaburova O.V.
,
Krylov S.V.
,
Mikhailova N.A.
,
Poddubikov A.V.
,
Lazarev S.A.
,
Zverev V.V.
,
Krylov V.N.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):155-160
10.36488/cmac.2020.2.155-160
PDF
Cite
Cite
×